IRIS Institutional Research Information System - AIR Archivio Istituzionale della Ricerca

BAREI, FRANCESCA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
AS - Asia 1.233
NA - Nord America 935
EU - Europa 500
SA - Sud America 115
AF - Africa 28
Continente sconosciuto - Info sul continente non disponibili 1
Totale 2.812
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 891
SG - Singapore 392
CN - Cina 375
IT - Italia 177
VN - Vietnam 138
BD - Bangladesh 102
BR - Brasile 91
HK - Hong Kong 75
DE - Germania 64
RU - Federazione Russa 60
FR - Francia 47
IN - India 45
NL - Olanda 32
CA - Canada 30
GB - Regno Unito 28
FI - Finlandia 26
KR - Corea 23
ES - Italia 18
CI - Costa d'Avorio 17
ID - Indonesia 15
JP - Giappone 15
TR - Turchia 14
PL - Polonia 13
AR - Argentina 10
MX - Messico 9
SE - Svezia 9
CO - Colombia 6
ZA - Sudafrica 6
JO - Giordania 5
AT - Austria 4
IE - Irlanda 4
IL - Israele 4
IQ - Iraq 4
PH - Filippine 4
PK - Pakistan 4
MA - Marocco 3
PT - Portogallo 3
PY - Paraguay 3
AE - Emirati Arabi Uniti 2
AL - Albania 2
CR - Costa Rica 2
CZ - Repubblica Ceca 2
EC - Ecuador 2
IR - Iran 2
NO - Norvegia 2
NP - Nepal 2
RO - Romania 2
TW - Taiwan 2
UA - Ucraina 2
UZ - Uzbekistan 2
VE - Venezuela 2
AO - Angola 1
AZ - Azerbaigian 1
BH - Bahrain 1
CH - Svizzera 1
CL - Cile 1
CY - Cipro 1
GR - Grecia 1
HT - Haiti 1
JM - Giamaica 1
KZ - Kazakistan 1
LK - Sri Lanka 1
LT - Lituania 1
LU - Lussemburgo 1
LV - Lettonia 1
MW - Malawi 1
MY - Malesia 1
NI - Nicaragua 1
PS - Palestinian Territory 1
SY - Repubblica araba siriana 1
XK - ???statistics.table.value.countryCode.XK??? 1
Totale 2.812
Salva come PNG Salva come JPEG
Città #
Ashburn 172
Singapore 153
Hefei 118
Santa Clara 90
Los Angeles 61
Milan 58
Dallas 53
Beijing 48
Hong Kong 47
San Jose 47
Council Bluffs 45
Ho Chi Minh City 43
Hanoi 38
Frankfurt am Main 29
Lauterbourg 29
Bengaluru 26
New York 22
Munich 20
Helsinki 19
Seoul 19
Boardman 18
Denver 18
Abidjan 17
Moscow 16
Buffalo 14
Montreal 14
Atlanta 13
Guangzhou 13
Jakarta 12
Chicago 11
Orem 10
Shanghai 10
Tokyo 10
Warsaw 10
Haiphong 9
Istanbul 8
Phoenix 8
Rome 8
São Paulo 8
Turin 7
Chennai 6
Da Nang 6
Houston 6
Manaus 6
Shenzhen 6
Washington 6
Amman 5
Chandler 5
Johannesburg 5
London 5
Madrid 5
Memphis 5
Nuremberg 5
Amsterdam 4
Ankara 4
Bologna 4
City of London 4
Dublin 4
Düsseldorf 4
Genoa 4
Lappeenranta 4
Miami 4
Naples 4
Shijiazhuang 4
Toronto 4
Berlin 3
Biên Hòa 3
Bogotá 3
Boston 3
Brasília 3
Brooklyn 3
Cangzhou 3
Casoria 3
Congonhas 3
Florence 3
Freiburg im Breisgau 3
Gravatá do Ibiapina 3
Lanzhou 3
Manchester 3
Mumbai 3
New Delhi 3
Newark 3
Poplar 3
Providence 3
Salt Lake City 3
San Francisco 3
Santo André 3
Seattle 3
Suzhou 3
Tampa 3
Thái Bình 3
Turku 3
Verona 3
Yongin-si 3
Zhengzhou 3
Ann Arbor 2
Aprilia 2
Belo Horizonte 2
Binzhou 2
Boise 2
Totale 1.590
Salva come PNG Salva come JPEG
Nome #
Omalizumab for the Treatment of Chronic Spontaneous Urticaria in Adults and Adolescents: An Eight-Year Real-Life Experience 203
Five-year real-world drug survival of dupilumab in severe atopic dermatitis and associate predictors 163
Five cases of new-onset pemphigus following vaccinations against coronavirus disease 2019 157
Ulcerative injection site reaction after third COVID-19 vaccine dose with mRNA-1273 151
Long-term efficacy and safety of dupilumab in adolescents with severe atopic dermatitis: a 3-year real-life study 150
Does body mass index impact the clinical response to dupilumab therapy in atopic dermatitis? A monocentric study of 170 patients 139
Three cases of symmetrical drug-related intertriginous and flexural exanthema (SDRIFE) induced by proton-pump inhibitors 127
Severe Allergic Contact Dermatitis to Hair Dye in a Patient With Atopic Dermatitis During Dupilumab Therapy 121
Safety and Effectiveness of Upadacitinib in Patients with Moderate-to-Severe Atopic Dermatitis Who Smoke: a 2-Year Real-Life Multicenter Study 120
A case of Grover disease treated with Dupilumab: Just serendipity or a future perspective? 118
Successful treatment of prurigo nodularis with upadacitinib 108
Efficacy and Drug Survival of Tralokinumab in Severe Atopic Dermatitis: An 18-Month Multicenter Experience 108
Abrupt Bullous Cutaneous Eruption After Application of Tacrolimus Ointment and Sun Exposure 105
Special sites in atopic dermatitis: Effectiveness of dupilumab on the hands in a single‐centre study on 485 patients 104
Effectiveness of dupilumab in tralokinumab-resistant patients with atopic dermatitis: A real-world experience from two referral centres 97
Effectiveness of dupilumab in atopic dermatitis on the head and neck: a single-center study on 553 patients 92
Assessment of patient-reported outcomes at 24 weeks of treatment with tralokinumab for atopic dermatitis: a multicentric real-life experience 90
Effectiveness of Tralokinumab Across Atopic Dermatitis Phenotypes 89
Reply to “New-onset bullous pemphigoid after inactivated Covid-19 vaccine: Synergistic effect of the Covid-19 vaccine and vildagliptin” 88
Upadacitinib improves symptoms of concomitant allergic rhinitis or allergic asthma in patients with severe atopic dermatitis: A 16-week multicentre retrospective study 86
Three-year observational study on the ​long-term efficacy and safety of dupilumab in elderly patients with severe atopic dermatitis 83
Dermoscopic features of dermal duct tumors 79
Dupilumab: a new frontier for chronic urticaria. A case series and review of the literature 77
Tralokinumab as a therapeutic option for patients with concurrent atopic dermatitis and alopecia areata 75
Effectiveness of Dupilumab and Tralokinumab in Treating Nummular Eczema 43
Therapeutic outcomes across Janus kinase inhibitors in prurigo nodularis 42
Five-year drug survival of dupilumab in atopic dermatitis: Italian landscape AD real-world study 40
Patch Testing Under Biologics: Six Cases From a Tertiary Centre 30
Cutaneous angiosarcoma of the head: a case from Italy 26
Phenotypic Switch From Atopic Dermatitis to Psoriasis During Dupilumab Therapy: A Real-Life Experience From a Tertiary Referral Center 11
Effectiveness of Tralokinumab for Moderate-to-Severe Atopic Dermatitis Involving the Head-and-Neck Area: A Multicenter Retrospective Cohort Study 11
Letter: Optimizing Dupilumab Dosing in Atopic Dermatitis: Real-World Evidence 11
Letter: Tralokinumab Dose Spacing in Moderate-to-Severe Atopic Dermatitis: A Real-World Case Series 7
Letter: Real-Life Improvement in Quality of Life With Delgocitinib in Chronic Hand Eczema 1
Patch test sensitization and permanent tattoos: epidemiological data from two referral centers 1
Totale 2.953
Salva come PNG Salva come JPEG
Categoria #
all - tutte 7.855
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 7.855
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/20222 0 0 0 0 0 0 0 0 0 0 2 0
2022/202346 0 0 0 8 6 4 1 6 8 3 7 3
2023/202492 1 9 5 7 24 5 7 7 2 7 9 9
2024/2025394 2 31 13 16 26 18 27 21 32 34 41 133
2025/20262.335 236 255 260 293 241 102 207 74 153 134 181 199
2026/202784 84 0 0 0 0 0 0 0 0 0 0 0
Totale 2.953